Surgery Partners (SGRY) Gains from Investment Securities (2014 - 2026)

Surgery Partners (SGRY) has 12 years of Gains from Investment Securities data on file, last reported at -$2.6 million in Q1 2026.

• Quarterly Gains from Investment Securities fell 124.3% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.1 million (down 142.46% YoY) and the FY2025 annual result came in at $1.2 million, down 95.16% from the prior year.
• Gains from Investment Securities grew to -$2.6 million in Q1 2026 per SGRY's latest filing, from -$30.3 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $47.6 million in Q4 2023, with the low at -$45.7 million in Q3 2023.
• Average Gains from Investment Securities over 5 years is $4.7 million, with a median of $5.6 million recorded in 2024.
• The widest YoY moves for Gains from Investment Securities: up 10975.0% in 2023, down 508.04% in 2023.
• Surgery Partners' Gains from Investment Securities stood at -$9.8 million in 2022, then surged by 585.71% to $47.6 million in 2023, then slumped by 51.47% to $23.1 million in 2024, then sank by 231.17% to -$30.3 million in 2025, then surged by 91.42% to -$2.6 million in 2026.
• Business Quant data shows SGRY's Gains from Investment Securities at -$2.6 million in Q1 2026, -$30.3 million in Q4 2025, and $12.2 million in Q3 2025.